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Abstract  
BACKGROUND: Hyaluronic filler is a sterile, biodegradable, viscoelastic, isotonic, transparent 
injectable gel implant which was approved by Food and Drug Administration (FDA) 1996. It is used 
for face reconstruction and modelling.    
CASE PRESENTATION: We report the case of a 40-year-old Serbian woman who presented after 
surgery of cleft lip, primary and secondary palate. We performed a biphasic therapy; in the first 
stage in the zone semimucosis lips is initially carried incision scar tissue. The second stage is 
placed hyaluronan implant. 
CONCLUSION: This case illustrates that, although hyaluronic fillers used mainly for correction of 
healthy tissue can be successfully used in the treatment of postoperative scars. 
 
 
 
 
 
 
Introduction 
 
In recent years there has been a growing 
interest in surgical procedures for facial rejuvenation. 
Hyaluronic acid is currently the most widely used 
dermal filler for the treatment of facial wrinkles [1]. 
Hyaluronic filler is a sterile, biodegradable, 
viscoelastic, isotonic, transparent injectable gel 
implant which was approved by Food and Drug 
Administration (FDA) 1996. It is used for face 
reconstruction and modeling. Aesthetic indications for 
lips are qualitative changes - shape, quantitative 
changes- size and biorevitalisation of lips, and 
reconstructive indications are asymmetry of lips, scars 
(postoperative, accidental, postinflamatory) and 
incompetent lips. The dermal fillers show an excellent 
tolerability and preservation of the dermal cells and 
matrix components [2]. 
Over the last decade, injectable soft tissue 
fillers have become an integral part of facial plastic 
surgery practice. The vast choice of new products 
being brought to the market, improved safety profile, 
lower costs in the current economic climate and high 
street availability mean that demand for nonsurgical 
rejuvenation treatments are increasing at an 
exponential rate and are no longer the preserve of the 
affluent [3]. 
We report a case of use of hyaluronic acid for 
the correction of postoperative scars after surgery 
cleft lip, primary and secondary palate. 
 
 
Case presentation 
 
We report the case of a 40-year-old Serbian 
woman who presented after surgery of cleft lip, 
primary and secondary palate. She was born with 
palate shisis, lip shisis and nose deformity.  She had 
more surgical interventions in order to take care of 
cleft palate. 
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Patient was admitted to the Aesthetic 
Education Center Medica Aesthetica in Belgrade, 
Serbia for aesthetic treatment after surgery. After 
clinical examination and specifying the desired look 
with a patient, correcting the application is accessed 
hyaluronic fillers. Preparing patients included the 
provision of short-term local infiltrative 2% lidocaine - 
epinephrine (lidocaine 40 mg/2 ml + epinephrine 
0.025 mg/2 ml) plexus anesthesia, local anesthesia 
terminal branches of the mandibular nerve and 
disinfection of the operating field. We used a cross-
linked hyaluronic acid (sodium hyaluronate) in the 
form of a gel concentration of 18.5 mg/g with the 
addition of antioxidants (mannitol) STYLAGE Special 
Lips, VIVACY laboratories, originating in France. 
Hyaluronic Filer is a non-animal origin, sterile and 
non-pyrogenic, physiological pH and osmolality. For 
injection is used needle 30G thickness, length 13 mm 
factory packed with hyaluronic fillers. When patients 
were done soft tissue reconstruction of the oral region, 
the application of hyaluronic acid injection was 
administered retrograde linear and bolus technique. 
We performed a biphasic therapy in the first stage in 
the zone semimucosis lips is initially carried incision 
scar tissue. We applied incision fibrous tissue release 
adhesions. The second stage is placed hyaluronan 
implant linear retrograde technique and bolus 
technique whereby the injected 0.33 ml of material. In 
order to achieve the most natural-looking lips in 
accordance with the accepted average proportions 
lips were drawn contours and minimum compensation 
amount of lip volume of 0.5 ml hyaluronic fillers 
(Figure 1). 
 
Figure 1: Lips patients before and after treatment with hyaluronic 
fillers 
Discussion 
 
Soft tissue augmentation with temporary 
dermal fillers is a continuously growing field, 
supported by the ongoing development and advances 
in technology and biocompatibility of the products 
marketed [1, 2]. The longer lasting, less immunogenic 
and thus more convenient hyaluronic acid (HA) fillers 
are encompassing by far the biggest share of the 
temporary dermal filler market [4-6]. 
The after multiple surgeries innate cleft 
palate, usually followed by corrective intervention of 
plastic surgeons. This requires hospitalization of 
patients, postoperative swelling and a longer 
recovery. Our patients wanted painless, comfortable 
treatment to correct the aesthetic defect. The case 
highlights the importance of proper injection 
technique, as well as the need for immediate 
recognition and treatment of similar scars [7]. The 
combination of treatments with fillers and surgical 
procedures may help process and provide more 
natural results than are possible with any of these 
techniques alone [8]. 
The HA dermal filler was associated with 
minimal discomfort, bruising or swelling of the lips; 
almost two-thirds of subjects (62%) returned to social 
engagements on the same day [4]. The high degree of 
subject satisfaction with aesthetic improvement in the 
lips, as well as the natural look and feel, indicates that 
this HA dermal filler represents an effective treatment 
option for patients requiring lip enhancement [9]. 
Injection of synthetic fillers for soft tissue 
augmentation is increasing over the last decade. One 
of the most common materials used is hyaluronic acid 
(HA) that is safe and temporary filler for soft tissue 
augmentation [7, 10]. It is imperative to any technique 
that direct, and preferably quantitative, feedback is 
given so that an immediate modification can be 
generated and successive patient outcomes improved 
[11]. Soft-tissue augmentation of the face is 
increasingly popular and the number of available filling 
agents has increased dramatically, improving the 
range of options for HA fillers. Meta-analysis proved 
both safety and efficacy for HA fillers [12]. 
Replacement fillers (such as the various 
formulations of HA) provide space-filling volume for a 
finite period of time [13]. Our expanding 
understanding of the physiological and immunological 
conditions of the skin and has prompted a growing 
field of aesthetic technology. Restorative procedures 
are taking advantage of improved and refined 
biotechnology, which continues to evolve at a rapid 
pace. Whereas surgical correction of skin laxity was 
the norm in years past, there are now many topical 
options available, and an ever-growing, increasingly 
perfected depot of minimally invasive, injectable 
dermal volumizers and stimulators, collectively 
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referred to as dermal fillers [14]. Use of dermal and 
subdermal fillers for facial rejuvenation has become 
popular because these treatments provide desirable 
aesthetic outcomes such as a harmonious, attractive 
appearance without invasive surgical procedures and 
without the downtime associated with surgery. While 
no procedure is free from risk to the patient, the 
appropriate use of fillers is generally associated with 
lower risk and less downtime compared with surgery 
[15]. 
In conclusion, this case illustrates that, 
although hyaluronic fillers used mainly for correction 
of healthy tissue can be successfully used in the 
treatment of postoperative scars. 
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